Company profile: Biosynex
1.1 - Company Overview
Company description
- Provider of rapid diagnostic solutions for health professionals, specializing in research, development and manufacturing of fast diagnosis tests on membrane support used in tropical and autoimmune diseases, emergency markers and infectious diseases; offerings include rapid diagnostic tests for prevention, screening and treatment, urinary infection test strips, and PathFast device performing up to six quantitative analyses in under 17 minutes without additional reagents.
Products and services
- Rapid Diagnostic Tests: Biosynex engineers and distributes clinical-grade membrane-supported rapid tests for health professionals, used in tropical, autoimmune, emergency marker, and infectious disease fields to facilitate prevention, screening, and treatment
- PathFast: A chemiluminescence-based analyzer using Magtration technology to perform up to six quantitative analyses in under 17 minutes without additional reagents
- Urinary Infection Test Strips: Multiparametric strips allowing quick testing of multiple urine parameters to detect bacterial infections and immune responses for targeted urinary diagnostics
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Biosynex
Cylex
HQ: United States
Website
- Description: Provider of in vitro diagnostic products designed to illuminate immunity in transplant medicine.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cylex company profile →
Adaltis
HQ: Italy
Website
- Description: Provider of in-vitro diagnostic systems and reagents to detect viral infections, diagnose immune system diseases, and measure hormone responses. Offers integrated platforms and automation including All-in One MDx for nucleic acid extraction and real-time PCR, Personal LAB and NEXgen microplate analyzers for ELISA/IFA, MOLgen syndromic PCR panels, AMPLIlab real-time PCR, and EXTRAlab liquid handling workstation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Adaltis company profile →
Interpace Biosciences
HQ: New Zealand
Website
- Description: Provider of molecular diagnostics and support services: PancraGEN assesses pancreaticobiliary cancer risk via DNA analysis; ThyGeNEXT uses NGS to identify mutations in thyroid nodules; ThyraMIR classifies indeterminate nodules with microRNA; RespriDx differentiates new primary lung tumors from metastases; BarreGen predicts Barrett’s Esophagus progression; NAVIGATOR aids testing access and financing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Interpace Biosciences company profile →
Advanced Instruments
HQ: United States
Website
- Description: Provider of scientific and analytical instruments and test kits for biopharmaceutical, clinical, food, dairy, and industrial microbiological markets, including freezing-point osmometers and the Solentim Cell Metric X for cell line development and assurance of clonality. Offers installation, qualification, training, validation, service agreements, and bioprocessing qualification services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Advanced Instruments company profile →
RTA Labs
HQ: Turkey
Website
- Description: Provider of medical and industrial biotechnology products, offering media in Petri, tube, and bottle; quick tests; chromogenic media; blood culture bottles; painting sets; hygislide; tuberculosis diagnosis; and sure check media, supported by an R&D laboratory suitable for molecular biology-genetics and immunology-serology-based studies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full RTA Labs company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Biosynex
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Biosynex
2.2 - Growth funds investing in similar companies to Biosynex
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Biosynex
4.2 - Public trading comparable groups for Biosynex
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →